GPCR

16.2105.32%
JS

Jun S. Yoon

Co- Founder, CFO & Secretary

Mr. Jun S. Yoon is Member of Business Advisory Board of GenEdit Inc. He has been the Chief Financial Officer at Structure Therapeutics Inc. since May 2022 and serves as its Secretary. He served as the Chief Operating Officer of Structure Therapeutics Inc. since February 2019 and served as its Chief Financial Officer and served as its Director since February 2019 until 2023. Mr. Yoon is Co-Founder of Structure Therapeutics Inc. Mr. Yoon has industry operating experience in building and leading venture-backed biotechnology companies. He most recently served as Vice President of Corporate Development at Cellerant Therapeutics, a biotechnology company developing cell- and antibody-based immunotherapies for hematologic malignancies and other blood-related disorders. His previous experiences include serving as Sr. Director of Licensing and Business Development at VIA Pharmaceuticals, a public biotechnology company focused on developing therapies for cardiovascular diseases. Mr. Yoon serves as Director of the GPCR Consortium. Mr. Yoon has also held business development roles at MemRx/Sagres Discovery, which focused on oncology therapeutics and was acquired by Chiron/Novartis, and was an early employee of Syrrx, a structure-based drug discovery company acquired by Takeda. Mr. Yoon earned his B.A. in molecular cell biology at the University of California, Berkeley.

Positions